Therapy of infections caused by opportunistic agents: fungi
Martín, E.; Nogales, M.C.; Flórez, C.; Vargas, J.; Sánchez, A.
Enfermedades Infecciosas y Microbiologia Clinica 7(Suppl 1): 62-66
1989
ISSN/ISBN: 0213-005X PMID: 2490490 Document Number: 343681
Document emailed within 1 workday
Related Documents
Crockett, C.O.; Guede-Guina, F.; Pugh, D.; Vangah-Manda, M.; Robinson, T.J.; Olubadewo, J.O.; Ochillo, R.F. 1992: Cassia alata and the preclinical search for therapeutic agents for the treatment of opportunistic infections in AIDS patients Cellular and Molecular Biology 38(7): 799-802Litiaeva, L.A. 1991: Chemotherapy of newborns with intestinal infections caused by opportunistic gram-negative aerobic bacteria Antibiotiki i Khimioterapiia 36(9): 37-38
Ablordeppey, S.Y.; Fan, P.; Ablordeppey, J.H.; Mardenborough, L. 1999: Systemic antifungal agents against AIDS-related opportunistic infections: current status and emerging drugs in development Current Medicinal Chemistry 6(12): 1151-1195
Stille, W.; Staszewski, S. 1988: Therapy of opportunistic infections in AIDS Verhandlungen der Deutschen Gesellschaft für Innere Medizin 94: 528-531
Alexander, W. 1993: AIDS, opportunistic infections, and drug therapy Nursing Outlook 41(3): 142
Baumgarten, R. 1992: Opportunistic infections in AIDS--diagnosis and therapy Zeitschrift für Arztliche Fortbildung 86(9): 433-436
Pagano, L.; Girmenia, C.; Mele, L.; Ricci, P.; Tosti, M.E.; Nosari, A.; Buelli, M.; Picardi, M.; Allione, B.; Corvatta, L.; D'Antonio, D.; Montillo, M.; Melillo, L.; Chierichini, A.; Cenacchi, A.; Tonso, A.; Cudillo, L.; Candoni, A.; Savignano, C.; Bonini, A.; Martino, P.; Del Favero, A. 2001: Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program Haematologica 86(8): 862-870
Marquardt, T.; Jablonowski, H. 2001: Opportunistic infections. Developments and trends since establishment of HAART therapy MMW Fortschritte der Medizin 143(Suppl 1): 56-60
Kudriavskaia, V.M.; Pyrit, L.A.; Rudenko, A.V. 1988: Complications caused by fungi of the genus Candida in patients with glomerulonephritis during pathogenetic therapy Vrachebnoe Delo 6: 82-85
Sunpath, H.; Edwin, C.; Chelin, N.; Nadesan, S.; Maharaj, R.; Moosa, Y.; Smeaton, L.; Court, R.; Knight, S.; Gwyther, E.; Murphy, R.A. 2012: Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 16(7): 917-923
Werneck-Silva, A.L.; Prado, I.B. 2009: Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy Journal of Gastroenterology and Hepatology 24(1): 135-139
Kirk, O.; Lundgren, J.D.; Pedersen, C.; Nielsen, H.; Gerstoft, J. 1999: Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy? Aids 13(13): 1647-1651
Prasitsuebsai, W.; Kariminia, A.; Puthanakit, T.; Lumbiganon, P.; Hansudewechakul, R.; Siew Moy, F.; Law, M.; Kumarasamy, N.; Razali, K.; Sirisanthana, V.; Sohn, A.H.; Chokephaibulkit, K. 2014: Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database Pediatric Infectious Disease Journal 33(7): 747-752
Prasitsuebsai, W.; Kariminia, A.; Puthanakit, T.; Lumbiganon, P.; Hansudewechakul, R.; Siew Moy, F.; Law, M.; Kumarasamy, N.; Razali, K.; Sirisanthana, V.; Sohn, A.H.; Chokephaibulkit, K. 2014: Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database Pediatric Infectious Disease Journal 33(7): 747-752
Altucci, P.; Abbate, G.; Esposito, S.; Izzo, E. 1994: Infections due to hard-to-treat germs. Endocarditis and nosocomial opportunistic infections Recenti Progressi in Medicina 85(5): 296-302
Podzamczer, D.; Barros, C.; Berenguer, J.; Gutiérrez, Félix.; Iribarren, Jé.Antonio.; Miró, Jé.M.; Molina, Jé.Pérez.; Podzamczer, D.; Aguirrebengoa, K.; Arribas, Jé.Ramón.; Boix, V.; Cahn, P.; Castro, A.; Caylá, J.; Cobo, J.; Corzo, J.Enrique.; de la Torre, J.; Dronda, F.; Ena, J.; Falcó, Vç.; Ferrer, E.; Labarga, P.; Locutura, J.; Mallolas, J.; Moreno, S.; Ocampo, A.; Ocaña, Ján.; Padilla, Bén.; Elías, Jús.Pérez.; Polo, R.; Portilla, Jín.; Riera, M.; Rivero, A.; Salavert, M.; Sanz, Jé. 2008: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. AIDS Study Group (GESIDA) and National AIDS Plan Expert Committee Enfermedades Infecciosas y Microbiologia Clinica 26(6): 356-379
Zacharova, T.; Tomenko, I. 1976: The immunological activity under a therapy with griseofulvin and pyrogenic agents in microsporum infections Dermatologische Monatschrift 162(2): 171-172
Gérard, M. 1993: Opportunistic infections Acta Urologica Belgica 61(1-2): 381-393
Lorian, V.; Pavletich, K. 1994: Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections Drugs under Experimental and Clinical Research 20(5): 209-214
Signorelli, C.; Boni, P.; Galli, M.G. 1988: Use of miocamycin in the therapy of cervical infections caused by Chlamydia trachomatis La Clinica Terapeutica 124(5): 383-386